Jeeyoung Kim1, Dong Yeop Kim2, Hye-Ryeon Heo1, Sun Shim Choi2, Seok-Ho Hong1, Woo Jin Kim1. 1. Department of Internal Medicine and Environmental Health Center, Kangwon National University Hospital, Chuncheon, South Korea. 2. Division of Biomedical Convergence, College of Biomedical Science, and Institute of Bioscience & Biotechnology, Kangwon National University, Chuncheon, South Korea.
Abstract
BACKGROUND: Inflammation is an important priming event in the pathogenesis of pulmonary diseases, including chronic obstructive pulmonary disease (COPD). Increasing evidence indicates that microRNAs (miRNAs) contribute to the pathogenesis of COPD by regulating inflammatory response. Therefore, it is necessary to investigate novel molecular targets in COPD without any validation in COPD samples in airway inflammation. The aim of our study is to reveal novel miRNAs that can influence molecular targets for COPD and to examine the underlying mechanism in airway inflammation. METHODS: We identified the downregulation of miR-181a-2-3p in the serum of COPD patients and further investigated the role of miR-181a-2-3p in cadmium (Cd)-induced inflammation of a human bronchial epithelial cell line (BEAS-2B) and normal human bronchial epithelial (NHBE) cells. RESULTS: Our results showed that expression of miR-181a-2-3p was significantly decreased in Cd-treated cells and silencing of miR-181a-2-3p enhanced Cd-induced inflammatory responses and inflammasome activation. This negative regulatory effect of miR-181a-2-3p on inflammation is partly mediated by the calcium signaling pathway. Furthermore, global gene expression profiling revealed that Toll-like receptor 4 or sequestosome 1 genes were identified as potential targets of miR-181a-2-3p, which were significantly upregulated by knockdown of miR-181a-2-3p in Cd-treated cells. CONCLUSIONS: Our results strongly suggest that miR-181a-2-3p has a critical role in Cd-induced inflammation of airway by regulating its potential target genes, which could be molecular targets for COPD.
BACKGROUND: Inflammation is an important priming event in the pathogenesis of pulmonary diseases, including chronic obstructive pulmonary disease (COPD). Increasing evidence indicates that microRNAs (miRNAs) contribute to the pathogenesis of COPD by regulating inflammatory response. Therefore, it is necessary to investigate novel molecular targets in COPD without any validation in COPD samples in airway inflammation. The aim of our study is to reveal novel miRNAs that can influence molecular targets for COPD and to examine the underlying mechanism in airway inflammation. METHODS: We identified the downregulation of miR-181a-2-3p in the serum of COPD patients and further investigated the role of miR-181a-2-3p in cadmium (Cd)-induced inflammation of a human bronchial epithelial cell line (BEAS-2B) and normal human bronchial epithelial (NHBE) cells. RESULTS: Our results showed that expression of miR-181a-2-3p was significantly decreased in Cd-treated cells and silencing of miR-181a-2-3p enhanced Cd-induced inflammatory responses and inflammasome activation. This negative regulatory effect of miR-181a-2-3p on inflammation is partly mediated by the calcium signaling pathway. Furthermore, global gene expression profiling revealed that Toll-like receptor 4 or sequestosome 1 genes were identified as potential targets of miR-181a-2-3p, which were significantly upregulated by knockdown of miR-181a-2-3p in Cd-treated cells. CONCLUSIONS: Our results strongly suggest that miR-181a-2-3p has a critical role in Cd-induced inflammation of airway by regulating its potential target genes, which could be molecular targets for COPD.
Authors: Qi-Jing Li; Jacqueline Chau; Peter J R Ebert; Giselle Sylvester; Hyeyoung Min; Gwen Liu; Ravi Braich; Muthiah Manoharan; Juergen Soutschek; Petra Skare; Lawrence O Klein; Mark M Davis; Chang-Zheng Chen Journal: Cell Date: 2007-03-22 Impact factor: 41.582
Authors: H Imaoka; T Hoshino; S Takei; T Kinoshita; M Okamoto; T Kawayama; S Kato; H Iwasaki; K Watanabe; H Aizawa Journal: Eur Respir J Date: 2007-11-07 Impact factor: 16.671
Authors: Emilie Doz; Nicolas Noulin; Elisabeth Boichot; Isabelle Guénon; Lizette Fick; Marc Le Bert; Vincent Lagente; Bernhard Ryffel; Bruno Schnyder; Valérie F J Quesniaux; Isabelle Couillin Journal: J Immunol Date: 2008-01-15 Impact factor: 5.422
Authors: Hamida Hammad; Marcello Chieppa; Frederic Perros; Monique A Willart; Ronald N Germain; Bart N Lambrecht Journal: Nat Med Date: 2009-03-29 Impact factor: 53.440
Authors: Mark M Perry; Sterghios A Moschos; Andrew E Williams; Neil J Shepherd; Hanna M Larner-Svensson; Mark A Lindsay Journal: J Immunol Date: 2008-04-15 Impact factor: 5.422
Authors: Noor Ahmad Shaik; Khalidah Nasser; Arif Mohammed; Abdulrahman Mujalli; Ahmad A Obaid; Ashraf A El-Harouni; Ramu Elango; Babajan Banaganapalli Journal: PLoS One Date: 2022-10-20 Impact factor: 3.752
Authors: J Ong; A Faiz; W Timens; M van den Berge; M M Terpstra; K Kok; A van den Berg; J Kluiver; C A Brandsma Journal: Sci Rep Date: 2019-12-03 Impact factor: 4.379